20.90
-0.09 (-0.43%)
| Previous Close | 20.99 |
| Open | 20.95 |
| Volume | 555,118 |
| Avg. Volume (3M) | 2,009,624 |
| Market Cap | 3,473,198,080 |
| Price / Earnings (TTM) | 232.22 |
| Price / Earnings (Forward) | 17.73 |
| Price / Sales | 1.42 |
| Price / Book | 1.16 |
| 52 Weeks Range | |
| Earnings Date | 30 Oct 2025 |
| Profit Margin | -44.90% |
| Operating Margin (TTM) | 7.99% |
| Diluted EPS (TTM) | -6.54 |
| Quarterly Revenue Growth (YOY) | -1.10% |
| Quarterly Earnings Growth (YOY) | -23.70% |
| Total Debt/Equity (MRQ) | 51.40% |
| Current Ratio (MRQ) | 2.12 |
| Operating Cash Flow (TTM) | 296.50 M |
| Levered Free Cash Flow (TTM) | 333.84 M |
| Return on Assets (TTM) | 1.57% |
| Return on Equity (TTM) | -31.33% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | Envista Holdings Corporation | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | 1.00 |
|
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company’s Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company’s Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 0.54% |
| % Held by Institutions | 116.92% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 24.00 (Barclays, 14.83%) | Buy |
| Median | 23.00 (10.05%) | |
| Low | 22.00 (JP Morgan, 5.26%) | Hold |
| Average | 23.00 (10.05%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 21.26 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JP Morgan | 16 Dec 2025 | 22.00 (5.26%) | Hold | 21.90 |
| Barclays | 09 Dec 2025 | 24.00 (14.83%) | Buy | 20.62 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 25 Nov 2025 | Announcement | Envista Announces Participation in 8th Annual Evercore Healthcare Conference |
| 29 Oct 2025 | Announcement | Envista Reports Third Quarter 2025 Results |
| 29 Oct 2025 | Announcement | Envista Announces Release of 2024 Sustainability Report |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |